Compare ALEMBIC PHARMA with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA VENUS REMEDIES ALEMBIC PHARMA/
VENUS REMEDIES
 
P/E (TTM) x 16.6 -7.5 - View Chart
P/BV x 6.6 0.5 1,323.3% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ALEMBIC PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
VENUS REMEDIES
Mar-18
ALEMBIC PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs664126 527.4%   
Low Rs41261 675.0%   
Sales per share (Unadj.) Rs208.7301.8 69.2%  
Earnings per share (Unadj.) Rs31.0-24.9 -124.6%  
Cash flow per share (Unadj.) Rs37.12.5 1,458.4%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.2293.3 49.2%  
Shares outstanding (eoy) m188.5212.34 1,527.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.60.3 832.3%   
Avg P/E ratio x17.4-3.8 -461.8%  
P/CF ratio (eoy) x14.536.7 39.5%  
Price / Book Value ratio x3.70.3 1,170.6%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,4611,154 8,793.8%   
No. of employees `000NA0.9 0.0%   
Total wages/salary Rs m7,467393 1,899.5%   
Avg. sales/employee Rs ThNM4,026.1-  
Avg. wages/employee Rs ThNM425.0-  
Avg. net profit/employee Rs ThNM-331.8-  
INCOME DATA
Net Sales Rs m39,3473,724 1,056.5%  
Other income Rs m9423 416.9%   
Total revenues Rs m39,4413,747 1,052.7%   
Gross profit Rs m8,736395 2,212.7%  
Depreciation Rs m1,152338 340.6%   
Interest Rs m184354 52.0%   
Profit before tax Rs m7,493-275 -2,721.8%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,56832 4,960.4%   
Profit after tax Rs m5,844-307 -1,904.1%  
Gross profit margin %22.210.6 209.4%  
Effective tax rate %20.9-11.5 -182.2%   
Net profit margin %14.9-8.2 -180.2%  
BALANCE SHEET DATA
Current assets Rs m19,5772,638 742.2%   
Current liabilities Rs m14,8962,305 646.4%   
Net working cap to sales %11.98.9 133.0%  
Current ratio x1.31.1 114.8%  
Inventory Days Days90135 66.3%  
Debtors Days Days4546 97.9%  
Net fixed assets Rs m27,0974,871 556.3%   
Share capital Rs m377123 305.5%   
"Free" reserves Rs m26,8113,496 767.0%   
Net worth Rs m27,1883,619 751.2%   
Long term debt Rs m4,9931,374 363.3%   
Total assets Rs m47,7787,509 636.3%  
Interest coverage x41.70.2 18,702.5%   
Debt to equity ratio x0.20.4 48.4%  
Sales to assets ratio x0.80.5 166.0%   
Return on assets %12.60.6 1,998.5%  
Return on equity %21.5-8.5 -253.5%  
Return on capital %23.61.6 1,491.8%  
Exports to sales %00-   
Imports to sales %013.9 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA517 0.0%   
Fx inflow Rs m19,4530-   
Fx outflow Rs m6,065517 1,174.2%   
Net fx Rs m13,388-517 -2,592.0%   
CASH FLOW
From Operations Rs m8,120514 1,578.5%  
From Investments Rs m-7,556-123 6,138.1%  
From Financial Activity Rs m590-387 -152.5%  
Net Cashflow Rs m1,1534 27,459.5%  

Share Holding

Indian Promoters % 74.1 32.9 225.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.2 1,611.1%  
FIIs % 9.1 0.6 1,569.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 66.4 20.9%  
Shareholders   49,328 20,121 245.2%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   NATCO PHARMA  FRESENIUS KABI ONCO.  FDC  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 500 Points Lower; Dow Futures Down by 77 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 553 points, down 1.1% at 47,794 levels.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 27, 2021 03:36 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS